Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cell Transplantation|August 21, 2018
Angiopoietin-1 Mimetic Peptide Promotes Neuroprotection after Stroke in Type 1 Diabetic RatsPoornima Venkat, Tao Yan, Michael Chopp, et al.
Scientific Reports|February 26, 2016
The Synthetic Tie2 Agonist Peptide Vasculotide Protects Renal Vascular Barrier Function In Experimental Acute Kidney InjuryEva Rübig, Jörg Stypmann, Paul Van Slyke, et al.
BMC Cancer|August 28, 2014
Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse modelElina Korpela, Darren Yohan, Lee Cl Chin, et al.
The Journal of Biological Chemistry|June 5, 2003
Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganizationZubin Master, Jennifer Tran, Aseem Bishnoi, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|March 23, 2011
Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortalitySascha David, Chandra C Ghosh, Philipp Kümpers, et al.
The American Journal of Pathology|August 28, 2004
Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver diseaseNicole L Ward, Alexandra L Haninec, Paul Van Slyke, et al.
Proteomics|February 27, 2010
Differential proteomic analysis of lymphatic, venous, and arterial endothelial cells extracted from bovine mesenteric vesselsVicky P K H Nguyen, George Hanna, Natalie Rodrigues, et al.
Scientific Reports|September 15, 2022
Adjunctive therapy with the Tie2 agonist Vasculotide reduces pulmonary permeability in Streptococcus pneumoniae infected and mechanically ventilated miceAina Lask, Birgitt Gutbier, Olivia Kershaw, et al.
Anesthesiology|October 3, 2017
Vasculotide, an Angiopoietin-1 Mimetic, Restores Microcirculatory Perfusion and Microvascular Leakage and Decreases Fluid Resuscitation Requirements in Hemorrhagic ShockMichelle Trieu, Matijs van Meurs, Anoek L I van Leeuwen, et al.
Cancer Research|January 18, 2008
Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growthJohn M L Ebos, Christina R Lee, Elena Bogdanovic, et al.
Pageof 3